Role of Nucleophosmin Mutations in AML

被引：0
|
作者：
Funato, Kotaro [1 ]
Sternberg, David W. [1 ]
机构：
[1] Mt Sinai Sch Med, Div Hematol Oncol, New York, NY USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1346 / 1346
页数：1
相关论文
共 50 条
  • [31] Release of angiopoietin-1 by acute myelogenous leukemia (AML) cells is increased by stromal cells and associated with mutations in the nucleophosmin (NPM) gene
    Hatfield, K.
    Hovland, R.
    Oyan, A. M.
    Kalland, K. H.
    Bruserud, O.
    EXPERIMENTAL HEMATOLOGY, 2007, 35 (09) : 72 - 72
  • [32] In human genome, generation of a nuclear export signal through duplication appears unique to nucleophosmin (NPM1) mutations and is restricted to AML
    A Liso
    A Bogliolo
    V Freschi
    M P Martelli
    S A Pileri
    M Santodirocco
    N Bolli
    M F Martelli
    B Falini
    Leukemia, 2008, 22 : 1285 - 1289
  • [33] Cytoplasmic expression of nucleophosmin does not predict favorable prognosis in AML patients
    Konoplev, S.
    Nguyen, M.
    Huang, X.
    Rassidakis, G. Z.
    Garcia-Manero, G.
    Yin, C. C.
    Amin, H.
    Schlette, E.
    Lin, P.
    Vega-Vazquez, F.
    Admirand, J.
    Huh, Y.
    You, J.
    Jorgensen, J. L.
    Kantarjian, H. M.
    Medeiros, L. J.
    Bueso-Ramos, C.
    LABORATORY INVESTIGATION, 2008, 88 : 260A - 260A
  • [34] Cytoplasmic expression of nucleophosmin does not predict favorable prognosis in AML patients
    Konopley, S.
    Lu, H.
    Rubin, J. B.
    Drahkin, H. A.
    Kantarjian, H. M.
    Andreeff, M.
    Konopleva, M.
    MODERN PATHOLOGY, 2008, 21 : 260A - 261A
  • [35] Cytoplasmic expression of nucleophosmin does not predict favorable prognosis in AML patients
    Konoplev, S.
    Nguyen, M.
    Huang, X.
    Rossidakis, G. Z.
    Garcia-Manero, G.
    Yin, C. C.
    Amin, H.
    Schlette, E.
    Lin, P.
    Vega-Vazquez, F.
    Admirand, J.
    Huh, Y.
    You, J.
    Jorgensen, J. L.
    Kantajian, H. M.
    Medeiros, L. J.
    Bueso-Ramos, C.
    MODERN PATHOLOGY, 2008, 21 : 260A - 260A
  • [36] AML-associated mutation of nucleophosmin compromises its interaction with nucleolin
    Sasinkova, Marketa
    Holoubek, Ales
    Otevrelova, Petra
    Kuzelova, Katerina
    Brodska, Barbora
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2018, 103 : 65 - 73
  • [37] PHF6-Somatic Mutations and Their Role in Pathophysiology of MDS and AML
    Przychodzen, Bartlomiej
    Gu, Xiaorong
    You, Dewen
    Hirsch, Cassandra M.
    Clemente, Michael J.
    Viny, Aaron D.
    Levine, Ross L.
    Haferlach, Torsten
    Maggendorfer, Manja
    Sekeres, Mikkael A.
    Carraway, Hetty E.
    Nazha, Aziz
    Enane, Francis
    Maciejewski, Jaroslaw P.
    BLOOD, 2015, 126 (23)
  • [38] Nucleophosmin mutations in Chinese adults with acute myelogenous leukemia
    Ruan, Guo-Rui
    Li, Jin-Lan
    Qin, Ya-Zhen
    Li, Ling-Di
    Xie, Min
    Chang, Yan
    Zhang, Yan
    Liu, Yan-Rong
    Jiang, Bin
    Chen, Shan-Shan
    Huang, Xiao-Jun
    ANNALS OF HEMATOLOGY, 2009, 88 (02) : 159 - 166
  • [39] HLA Class I-Specific Effects in AML with Mutated Nucleophosmin
    Kuzelova, Katerina
    Rollig, Christoph
    Racil, Zdenek
    Stickel, Juliane S.
    Brodska, Barbora
    Schetelig, Johannes
    Thiede, Christian
    Ehninger, Gerhard
    Helbig, Grzegorz
    Kyrcz-Krzemien, Slawomira
    Mayer, Jiri
    Cetkovsky, Petr
    BLOOD, 2016, 128 (22)
  • [40] FOXM1 Binds Nucleophosmin in AML and Confers Resistance to Chemotherapy
    Khan, Irum
    Zia, Maryam
    Halasi, Marianna
    Gann, Peter
    Gaitonde, Sujata
    Gartel, Andrei
    BLOOD, 2015, 126 (23)
12345